1. Home
  2. AQB vs XXII Comparison

AQB vs XXII Comparison

Compare AQB & XXII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AQB
  • XXII
  • Stock Information
  • Founded
  • AQB 1991
  • XXII 1998
  • Country
  • AQB United States
  • XXII United States
  • Employees
  • AQB N/A
  • XXII N/A
  • Industry
  • AQB
  • XXII Medicinal Chemicals and Botanical Products
  • Sector
  • AQB
  • XXII Health Care
  • Exchange
  • AQB Nasdaq
  • XXII Nasdaq
  • Market Cap
  • AQB 7.1M
  • XXII 6.2M
  • IPO Year
  • AQB N/A
  • XXII N/A
  • Fundamental
  • Price
  • AQB $1.73
  • XXII $1.50
  • Analyst Decision
  • AQB
  • XXII
  • Analyst Count
  • AQB 0
  • XXII 0
  • Target Price
  • AQB N/A
  • XXII N/A
  • AVG Volume (30 Days)
  • AQB 441.0K
  • XXII 3.3M
  • Earning Date
  • AQB 11-04-2025
  • XXII 11-11-2025
  • Dividend Yield
  • AQB N/A
  • XXII N/A
  • EPS Growth
  • AQB N/A
  • XXII N/A
  • EPS
  • AQB N/A
  • XXII N/A
  • Revenue
  • AQB N/A
  • XXII $21,362,000.00
  • Revenue This Year
  • AQB N/A
  • XXII N/A
  • Revenue Next Year
  • AQB N/A
  • XXII $126.57
  • P/E Ratio
  • AQB N/A
  • XXII N/A
  • Revenue Growth
  • AQB N/A
  • XXII N/A
  • 52 Week Low
  • AQB $0.47
  • XXII $1.46
  • 52 Week High
  • AQB $2.95
  • XXII $434.70
  • Technical
  • Relative Strength Index (RSI)
  • AQB 49.40
  • XXII 40.72
  • Support Level
  • AQB $1.67
  • XXII $1.46
  • Resistance Level
  • AQB $1.97
  • XXII $1.60
  • Average True Range (ATR)
  • AQB 0.27
  • XXII 0.09
  • MACD
  • AQB -0.07
  • XXII 0.01
  • Stochastic Oscillator
  • AQB 4.69
  • XXII 16.18

About AQB AquaBounty Technologies Inc.

AquaBounty Technologies Inc is engaged in the field of land-based aquaculture and the use of technology to improve the productivity and sustainability. The company's objective is to ensure the availability of high-quality seafood to meet consumer demand while addressing critical production constraints in the popular farmed species.

About XXII 22nd Century Group Inc.

22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.

Share on Social Networks: